Table 2 Distribution of patients according to the follow-up of the renal function and the degree of pyelocalyceal dilation (Valayer-Cendron)
Creat (μmol/L) | Before surgery | 3 months after surgery | 6 months after surgery | |||
|---|---|---|---|---|---|---|
GVC II | GVC III | GVC II | GVC III | GVC II | GVC III | |
80–120 | 1 | 2 | 4 | 2 | 5 | 7 |
[120–160] | 3 | – | 1 | 3 | – | – |
[160–300] | – | 6 | – | 2 | – | – |